Multicentre phase II study of bifractionated CPT-11 with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer pretreated with FOLFOX

This multicentre phase II study was designed to evaluate the antitumour activity and toxicity of bifractionated camptothecin (CPT-11) and 5-fluorouracil/ leucovorin (5-FU/LV) in the treatment of patients with metastatic colorectal cancer (MCC) who had been pretreated with 5-FU/LV-oxaliplatin (FOLFOX...

Descripción completa

Detalles Bibliográficos
Autores principales: Recchia, F, Saggio, G, Nuzzo, A, Lalli, A, Lullo, L Di, Cesta, A, Rea, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409925/
https://www.ncbi.nlm.nih.gov/pubmed/15467766
http://dx.doi.org/10.1038/sj.bjc.6602194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409925/
https://www.ncbi.nlm.nih.gov/pubmed/15467766
http://dx.doi.org/10.1038/sj.bjc.6602194

Ejemplares similares